Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,167
Total Claims
$525K
Drug Cost
631
Beneficiaries
$832
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
+16%
Cost per patient vs peers
$832 vs $719 avg
+30%
Brand preference vs peers
8.7% vs 6.7% avg
Brand vs Generic
Brand: 1,018 claims · $374K
Generic: 10,714 claims · $146K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 79 | $57K |
| Sitagliptin Phosphate | 43 | $31K |
| Linagliptin | 37 | $30K |
| Sacubitril/Valsartan | 27 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 57 | $21K |
| Tirzepatide | 18 | $20K |
| Mirabegron | 22 | $13K |
| Rivaroxaban | 14 | $13K |
| Semaglutide | 13 | $13K |
| Fluticasone/Umeclidin/Vilanter | 11 | $11K |
| Atorvastatin Calcium | 715 | $9,690 |
| Diclofenac Sodium | 449 | $9,443 |
| Cyclosporine | 19 | $9,170 |
| Dapagliflozin Propanediol | 13 | $8,992 |
| Fluticasone Propion/Salmeterol | 12 | $6,138 |
Prescribing Profile
Patient Profile
75
Avg Age
62%
Female
1.79
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data